21622477

Gambineri A

2011

A combination of polymorphisms in HSD11B1 associates with in vivo 11{beta}-HSD1 activity and metabolic syndrome in women with and without polycystic ovary syndrome.

21622478

Idkowiak J

2011

Premature adrenarche: novel lessons from early onset androgen excess.

21623779

Unluhizarci K

2012

Non polycystic ovary syndrome-related endocrine disorders associated with hirsutism.

21623990

Li C

2011

First evidence of genetic association between the MIF-173G/C single-nucleotide polymorphisms and polycystic ovary syndrome.

21625791

Azevedo MF

2011

[Elevated blood pressure in women with polycystic ovary syndrome: prevalence and associated risk factors].

21627406

Toscani MK

2011

Effect of high-protein or normal-protein diet on weight loss, body composition, hormone, and metabolic profile in southern Brazilian women with polycystic ovary syndrome: a randomized study.

21627426

Lakhani K

2011

Symmetric dimethylarginine (SDMA) is raised in women with polycystic ovary syndrome: a pilot study.

21628302

Toulis KA

2011

Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome.

21629269

Barr S

2011

Habitual dietary intake, eating pattern and physical activity of women with polycystic ovary syndrome.

21631446

Johnson NP

2011

Analysis of factors predicting success of metformin and clomiphene treatment for women with infertility owing to PCOS-related ovulation dysfunction in a randomised controlled trial.

21632811

Ib??ez L

2011

Early metformin therapy (age 8-12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence.

21637951

Ranjzad F

2012

A common variant in the adiponectin gene and polycystic ovary syndrome risk.

21640360

Vargas ML

2011

Metabolic and endocrine effects of long-chain versus essential omega-3 polyunsaturated fatty acids in polycystic ovary syndrome.

21641593

Carlomagno G

2011

The D-chiro-inositol paradox in the ovary.

21641713

Poujade O

2011

Surgical management of infertility due to polycystic ovarian syndrome after failure of medical management.

21642384

Frolova AI

2011

Glucose transporters in the uterus: an analysis of tissue distribution and proposed physiological roles.

21644399

Pehlivanov BK

2011

Anti-M?llerian hormone in women with polycystic ovary syndrome.

21645371

Xu X

2011

Family association study between INSR gene polymorphisms and PCOS in Han Chinese.

21645894

Schlaff WD

2011

Increasing burden of institutional review in multicenter clinical trials of infertility: the Reproductive Medicine Network experience with the Pregnancy in Polycystic Ovary Syndrome (PPCOS) I and II studies.

21645911

Nandalike K

2011

Screening for sleep-disordered breathing and excessive daytime sleepiness in adolescent girls with polycystic ovarian syndrome.

21646367

G?mez R

2011

Evidences for the existence of a low dopaminergic tone in polycystic ovarian syndrome: implications for OHSS development and treatment.

21647639

Gulekli B

2011

IVM is an alternative for patients with PCO after failed conventional IVF attempt.

21649996

Moosov? M

2011

[A relation between the polycystic ovary syndrome and the status of ovarian hyperstimulation syndrome in IVF patients after controlled hyperstimulation].

21650066

Whitaker KN

2011

Polycystic ovary syndrome: an overview.

21654606

Palomba S

2011

[Sex ratio in the offspring of pregnant women with polycystic ovary syndrome: effect of different phenotypes].

21655296

Dessapt-Baradez C

2011

Circulating vascular progenitor cells and central arterial stiffness in polycystic ovary syndrome.

21657888

Anaforoglu I

2011

Higher metabolic risk with National Institutes of Health versus Rotterdam diagnostic criteria for polycystic ovarian syndrome in Turkish women.

21667435

Macut D

2011

Insulin resistance in non-obese women with polycystic ovary syndrome: relation to byproducts of oxidative stress.

21669410

Wei LN

2011

Abnormal expression of growth differentiation factor 9 and bone morphogenetic protein 15 in stimulated oocytes during maturation from women with polycystic ovary syndrome.

21671782

Pontikis C

2011

The incretin effect and secretion in obese and lean women with polycystic ovary syndrome: a pilot study.

21676419

Lee SH

2011

Mitochondrial DNA copy number in peripheral blood in polycystic ovary syndrome.

21677061

Lambert-Messerlian G

2011

First assessment of menstrual cycle function and reproductive endocrine status in Samoan women.

21677353

Grzybowska M

2011

[Metformin - mechanisms of action and use for the treatment of type 2 diabetes mellitus].

21680659

Frolova AI

2011

Dehydroepiandrosterone inhibits glucose flux through the pentose phosphate pathway in human and mouse endometrial stromal cells, preventing decidualization and implantation.

21686234

Vaughan DE

2011

PAI-1 antagonists: the promise and the peril.

21688169

Shi X

2011

Co-involvement of psychological and neurological abnormalities in infertility with polycystic ovarian syndrome.

21693034

Kamath MS

2011

Letrozole or clomiphene citrate as first line for anovulatory infertility: a debate.

21695939

Punevska M

2011

[Laparoscopic ovarian drilling and biopsy in women with polycystic ovaries (PCOS) and infertility].

21695966

Ganzhi? VV

2011

[Novel technologies in surgical treatment of cholelithiasis and benign ovarial tumours in ovarial polycystic syndrome using generator of automatic welding of the soft tissues].

21696337

Sharifi F

2012

Serum magnesium concentrations in polycystic ovary syndrome and its association with insulin resistance.

21701160

Barton JC

2011

Hemochromatosis, HFE C282Y homozygosity, and polycystic ovary syndrome: report of two cases and possible effects of androgens and hepcidin.

21701605

Brady C

2009

Polycystic ovary syndrome and its impact on women's quality of life: More than just an endocrine disorder.

21703610

Li Y

2011

Polycystic ovary syndrome is associated with negatively variable impacts on domains of health-related quality of life: evidence from a meta-analysis.

21704118

Haendler B

2012

Recent developments in antiandrogens and selective androgen receptor modulators.

21704212

Ladson G

2011

Effects of metformin in adolescents with polycystic ovary syndrome undertaking lifestyle therapy: a pilot randomized double-blind study.

21704986

Shalom-Paz E

2011

Effects of different body mass indices on in vitro maturation in women with polycystic ovaries.

21710394

Padmanabhan V

2011

Developmental origin of reproductive and metabolic dysfunctions: androgenic versus estrogenic reprogramming.

21711376

Harrison CL

2012

The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome.

21714454

Eliakim A

2010

Endogenous hyperandrogenism and exercise capacity lessons from the exercise-congenital adrenal hyperplasia model.

21714456

Jehaimi CT

2010

Polycystic ovaries and adrenal insufficiency in a young pubescent female with lipoid congenital adrenal hyperplasia due to splice mutation of the StAR gene: a case report and review of the literature.

21717173

Vural P

2011

Lack of association between intercellular adhesion molecule-1 (ICAM-1) polymorphisms and polycystic ovary syndrome.

21717405

Franik G

2011

Clinical observations and hormone screenings of patients with non-standard hypertrophy of the adrenal cortex.

21717406

Mehrabian F

2011

The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria.

21717407

Foltyn W

2011

Selected markers of endothelial dysfunction in women with polycystic ovary syndrome.

21718997

Shalom-Paz E

2011

Priming in vitro maturation cycles with gonadotropins: salvage treatment for nonresponding patients.

21719005

Lie Fong S

2011

Serum anti-M?llerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.

21719011

Abdel-Rahman MY

2011

Prevalence of abnormal glucose metabolism in a cohort of Arab women with polycystic ovary syndrome.

21719186

Caglar G

2014

Response: urinary albumin excretion in polycystic ovary syndrome: contributions from a study considering low grade albuminuria.

21720879

Hu W

2011

Expression and regulation of adipocyte fatty acid binding protein in granulosa cells and its relation with clinical characteristics of polycystic ovary syndrome.

21722750

Wu CC

2011

The role of 20-HETE in androgen-mediated hypertension.

21722894

Lam PM

2011

The reproductive and metabolic effect of rosiglitazone on Chinese women with polycystic ovarian syndrome--a double-blind randomized placebo-controlled study.

21723443

Ladson G

2011

Racial influence on the polycystic ovary syndrome phenotype: a black and white case-control study.

21724534

Karkanaki A

2011

The clinical significance of anti-M?llerian hormone evaluation in gynecological endocrinology.

21724569

Mellembakken JR

2011

Sustained fertility from 22 to 41 years of age in women with polycystic ovarian syndrome.

21725075

Barry JA

2011

Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis.

21731374

Maharjan R

2010

Effect of Aloe barbadensis Mill. formulation on Letrozole induced polycystic ovarian syndrome rat model.

21733371

He LR

2011

[Clinical significance of counting follicles in diagnosis of polycystic ovary syndrome by the three-dimensional ultrasound imaging with sonography based automated volume calculation method].

21733508

Essah PA

2011

Effect of combined metformin and oral contraceptive therapy on metabolic factors and endothelial function in overweight and obese women with polycystic ovary syndrome.

21733949

Ercan EA

2011

Factors associated with increased carotid intima-media thickness and being nondipper in nonobese and normotensive young patients affected by PCOS.

21734263

Hara S

2011

Bezafibrate restores the inhibition of FSH-induced follicular development and steroidogenesis by tumor necrosis factor-alpha through peroxisome proliferator-activated receptor-gamma pathway in an in vitro mouse preantral follicle culture.

21735412

Moran LJ

2011

Lifestyle changes in women with polycystic ovary syndrome.

21735689

Wikarek T

2011

[Anti-M?llerian hormone and fertility disturbances in obese women and women with polycystic ovary syndrome].

21735693

Serdy?ska-Szuster M

2011

[Effects of metformin therapy on markers of coagulation disorders in hyperinsulinemic women with polycystic ovary syndrome].

21737073

Li HW

2011

Evaluation of serum antimullerian hormone and inhibin B concentrations in the differential diagnosis of secondary oligoamenorrhea.

21740456

Pepene CE

2012

Evidence for visfatin as an independent predictor of endothelial dysfunction in polycystic ovary syndrome.

21741437

McNeilly AS

2012

Diagnostic applications for inhibin and activins.

21741493

Ngo DT

2011

Determinants of insulin responsiveness in young women: Impact of polycystic ovarian syndrome, nitric oxide, and vitamin D.

21744744

Ciotta L

2011

Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial.

21745536

Cloke B

2012

The role of androgens and the androgen receptor in cycling endometrium.

21747019

Jason J

2011

Polycystic ovary syndrome in the United States: clinical visit rates, characteristics, and associated health care costs.

21752527

Ska?ba P

2011

Is the plasma anti-M?llerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?

21752757

Kjerulff LE

2011

Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis.

21755338

Abu Hashim H

2011

Laparoscopic ovarian diathermy after clomiphene failure in polycystic ovary syndrome: is it worthwhile? A randomized controlled trial.

21755675

Rodgers RJ

2010

The roles of the ovarian extracellular matrix in fertility.

21756068

Kurdoglu Z

2012

Serum myeloperoxidase and adenosine deaminase activities in polycystic ovary syndrome.

21756079

Asadipooya K

2012

Pioglitazone reduces central obesity in polycystic ovary syndrome women.

21756081

Koiou E

2012

Weight loss significantly reduces serum lipocalin-2 levels in overweight and obese women with polycystic ovary syndrome.

21762204

Hsia Y

2012

Unlicensed use of metformin in children and adolescents in the UK.

21762890

Zhao X

2011

Defining hirsutism in Chinese women: a cross-sectional study.

21769526

Nair MK

2012

Menstrual irregularity and poly cystic ovarian syndrome among adolescent girls--a 2 year follow-up study.

21770828

Karabulut A

2012

Evaluation of body fat distribution in PCOS and its association with carotid atherosclerosis and insulin resistance.

21770836

Palomba S

2012

Metformin administration in patients with polycystic ovary syndrome who receive gonadotropins for in vitro fertilization cycles: 10-year experience in a large infertile population.

21770837

Abu Hashim H

2012

Minimal stimulation or clomiphene citrate as first-line therapy in women with polycystic ovary syndrome: a randomized controlled trial.

21770838

Glintborg D

2012

Smoking is associated with increased adrenal responsiveness, decreased prolactin levels and a more adverse lipid profile in 650 white patients with polycystic ovary syndrome.

21771766

Kuchenbecker WK

2011

In women with polycystic ovary syndrome and obesity, loss of intra-abdominal fat is associated with resumption of ovulation.

21777422

Weghofer A

2011

Anti-Mullerian hormone levels decline under hormonal suppression: a prospective analysis in fertile women after delivery.

21778215

Victor VM

2011

Induction of oxidative stress and human leukocyte/endothelial cell interactions in polycystic ovary syndrome patients with insulin resistance.

21779653

Le?o LM

2011

[Dunnigan-type familial partial lipodystrophy: attention to precocious diagnosis].

21780950

Li PF

2012

Establishment of polycystic ovary syndrome-derived human embryonic stem cell lines.

21782166

de Paula Guedes Neto E

2011

Prospective, randomized comparison between raloxifene and clomiphene citrate for ovulation induction in polycystic ovary syndrome.